Tranexyl-E

Addressing Excessive Bleeding, Managing Hemostasis

10x10 Tablets

Pharma

Hemostatic

Product highlights

Combination of Etamsylate + Tranexamic Acid for effective hemostatic action
Helps reduce bleeding time and improve platelet aggregation
Improves capillary wall stability
Powerful anti-fibrinolytic action
Effective management of menorrhagia and dysfunctional uterine bleeding

Tranexyl-E Tablets is a hemostatic combination containing Etamsylate and Tranexamic Acid formulated to manage excessive bleeding conditions. The formulation helps reduce blood loss, stabilize capillaries, and improve platelet function for better hemostatic control.

Dosage Form

Tablets

Product Name

Tranexyl-E Tablets

Composition

Etamsylate – 250 mg, Tranexamic Acid – 250 mg

Therapeutic Segment

Gynecology
Hemostatic Therapy
Women's Health

Pharmacological Action

Reduces bleeding time
Increases platelet aggregation
Improves capillary resistance and stability
Prevents excessive fibrinolysis

Mechanism

Etamsylate: Promotes platelet adhesiveness
Etamsylate: Increases resistance of capillary endothelium
Tranexamic Acid: Potent anti-fibrinolytic agent
Tranexamic Acid: Prevents breakdown of blood clots by inhibiting plasmin activity

Key Clinical Benefits

Effective control of excessive menstrual bleeding
Helps reduce blood loss in dysfunctional uterine bleeding
Improves hemostatic stability
Enhances patient comfort and quality of life
Supports rapid bleeding control

Key Indications

Menorrhagia
Dysfunctional uterine bleeding (DUB)
Hematemesis
Short-term bleeding prevention in hemophilia patients

Administration

To be taken orally after meals or as directed by the physician.

Recommended Usage

One tablet two to three times daily or as prescribed by the healthcare professional.